TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2012

A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.

Heather A Wakelee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.